Mikhail Eydelman
Compliance Officer bij VAXCYTE, INC.
Vermogen: 2 M $ op 30-04-2024
Oorsprong van het eerstegraads netwerk van Mikhail Eydelman
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Public Company | Biotechnology | 23 | |
Subsidiary | Pharmaceuticals: Major | 7 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Mikhail Eydelman via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
CARDINAL HEALTH, INC. | Medical Distributors | Corporate Officer/Principal Corporate Officer/Principal | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Investor Relations Contact Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
TELEFLEX INCORPORATED | Medical Specialties | Director of Finance/CFO | |
CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Corporate Officer/Principal | |
NEOGENOMICS, INC. | Medical/Nursing Services | General Counsel | |
STANDARD BIOTOOLS INC. | Medical Specialties | Corporate Officer/Principal Chairman | |
KINEMED INC | Miscellaneous Commercial Services | Director/Board Member | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | General Counsel | |
Plexxikon, Inc.
Plexxikon, Inc. Miscellaneous Commercial ServicesCommercial Services Plexxikon, Inc. provides clinical and medical drug discovery and development services. The company was founded by Joseph P. Schlessinger, Thomas Richard Kassberg, Sung-hou Kim and K. Peter Hirth in 2001 and is headquartered in Berkeley, CA. | Miscellaneous Commercial Services | Founder | |
IRONWOOD PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Administrative Officer | |
Iconic Therapeutics, Inc.
Iconic Therapeutics, Inc. BiotechnologyHealth Technology Iconic Therapeutics, Inc. engages in the development of novel therapeutics for the treatment of serious eye disorders. Its product ICON-1, is a novel immune-conjugate fusion protein that works with the body’s immune system to address the root causes of inflammation and angiogenesis together, potentially altering the course of causes of blindness. The company was founded by Alan Garen, Kirk Dornbush, and Michael I. Sherman in 2003 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member | |
University of Notre Dame | College/University | Masters Business Admin Undergraduate Degree | |
APP Pharmaceuticals, Inc.
APP Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology APP Pharmaceuticals, Inc. develops, manufactures and markets injectable pharmaceutical products with a primary focus on the oncology, anti-infective, anesthetic/analgesic and critical care markets. It offers one of the most comprehensive product portfolios used in hospitals, long-term care facilities, alternate care sites and clinics within North America and manufactures a comprehensive range of dosage formulations. The company is headquartered in Los Angeles, CA. | Pharmaceuticals: Major | Chief Operating Officer | |
Fresenius Kabi Pharmaceuticals Holding LLC
Fresenius Kabi Pharmaceuticals Holding LLC Pharmaceuticals: MajorHealth Technology Fresenius Kabi Pharmaceuticals Holding LLC is a pharmaceutical company, which engages in the development, manufacturing, and marketing of injectable pharmaceutical products. It primarily focuses on the injectable oncology, anti-infective, anesthetic/analgesic, and critical care markets. The firm manufactures products in each of the three basic forms, which include liquid, powder, and lyophilized or freeze-dried. Its products are generally used in hospitals, long-term care facilities, alternate care sites and clinics. The company was founded on July 2, 2008 and is headquartered in Wilmington, DE. | Pharmaceuticals: Major | Chief Operating Officer | |
Afferent Pharmaceuticals, Inc.
Afferent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Afferent Pharmaceuticals, Inc. develops selective drugs for the treatment of debilitating neurogenic disorders. It offers programs for respiratory, cardiovascular, chronic pain, biology, and clinical trials. The firm offers drugs for osteoarthritis pain, treatment-refractory chronic cough, and interstitial cystitis or bladder pain syndrome. The company was founded by Anthony P. Ford in December 2009 and is headquartered in San Mateo, CA. | Pharmaceuticals: Major | Director/Board Member | |
Skadden, Arps, Slate, Meagher & Flom LLP
Skadden, Arps, Slate, Meagher & Flom LLP Miscellaneous Commercial ServicesCommercial Services Skadden, Arps, Slate, Meagher & Flom LLP provides legal advisory services. Its practice areas include mergers and acquisitions, finance, litigation, corporate finance, insurance, tax, labor and employment, political law, private equity, corporate, antitrust, white collar crime, international, regulatory, and legislation. The company was founded by Marshall Skadden, John Slate, and Les Arps in 1948 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Tufts University | College/University | Undergraduate Degree | |
The University of Arkansas | College/University | Undergraduate Degree Doctorate Degree | |
Northwest Missouri State University | College/University | Undergraduate Degree | |
St. Louis University | College/University | Masters Business Admin | |
Santa Clara University | College/University | Masters Business Admin Undergraduate Degree | |
University of Western Kentucky | College/University | Undergraduate Degree | |
University of California, Davis | College/University | Corporate Officer/Principal Undergraduate Degree | |
Celera Diagnostics LLC
Celera Diagnostics LLC Medical/Nursing ServicesHealth Services Celera Diagnostics LLC discovers, develops and commercializes molecular diagnostics. The firm enables physicians to diagnose, monitor and treat disease. It manufactures products for infectious disease testing and for genetic conditions such as cystic fibrosis. The company was founded in 2001 by Kathy Ordoñez and is headquartered in Alameda, CA. | Medical/Nursing Services | Corporate Officer/Principal | |
Massachusetts Bar Association
Massachusetts Bar Association Miscellaneous Commercial ServicesCommercial Services The Massachusetts Bar Association is a non-profit organization that serves the legal profession and the public by promoting the administration of justice, legal education, professional excellence, and respect for the law. The MBA is based in Boston, MA. The organization offers various membership advantages, volunteer opportunities, and educational resources such as CLE programs, practicing with professionalism courses, and publications like the ejournal and Lawyers Journal. The MBA also provides advocacy services, public resources, and exclusive benefits to its members such as the Lawyer Referral Service, Insurance Agency, and MBA On Demand. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Juvaris BioTherapeutics, Inc.
Juvaris BioTherapeutics, Inc. BiotechnologyHealth Technology Juvaris BioTherapeutics, Inc. develops novel, adjuvanted vaccines and immunotherapeutics to treat infectious disease and cancer. The company was founded by Martin D. Cleary, Jeff Fairman and Steven W. Dow in February 2003 and is headquartered in Burlingame, CA. | Biotechnology | Chief Executive Officer Founder | |
Infectious Diseases Society of America
Infectious Diseases Society of America Miscellaneous Commercial ServicesCommercial Services The Infectious Diseases Society of America is a non-profit company that provides clinical practice guidelines development and guideline panelists for infectious diseases. The company is based in Arlington, VA and has subsidiaries in the United States. The company specializes in antimicrobial stewardship and have established Antimicrobial Stewardship Centers of Excellence. The CEO of the company is Christopher Busky. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
The American Association of Immunologists | Corporate Officer/Principal | ||
Applied Biosystems, Inc.
Applied Biosystems, Inc. Medical SpecialtiesHealth Technology Applied Biosystems, Inc. is a company that provides integrated systems for sequencing, flow cytometry, and various types of PCR. The company is based in Foster City, CA. The company's products cover the entire process from sample preparation to data analysis. The company was founded by Chris Yoo, Marvin H. Caruthers, Michael W. Hunkapiller, and Leroy E. Hood. Applied Biosystems was acquired by Invitrogen Corp. from Applera Corp. on November 21, 2008 for $6,417.85 million. | Medical Specialties | Corporate Officer/Principal | |
Greater Boston Legal Services, Inc.
Greater Boston Legal Services, Inc. Miscellaneous Commercial ServicesCommercial Services Greater Boston Legal Services, Inc. provides free civil legal assistance to low-income people. It offers advice and represent people in court, before agencies, and before city councils and the state legislature. The company was founded in 1976 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Director/Board Member | |
Colby Pharmaceutical Co.
Colby Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Colby is transitioning to a clinical stage drug development company. The company was launched as a Wisconsin Alumni Research Foundation (WARF) spin-out and is strategically aligned with leading clinicians and drug discovery scientists at the University of Wisconsin Paul P. Carbone Comprehensive Cancer Center (UWCCC). Colby is accessing data from funded grants and private investment to develop its therapeutic drugs for therapy-resistant and hypoxic conditions. Colby's lead drugs have unique mechanisms of action and target specific pathways. The company is focused on clinical development of its lead drugs, CPC-100 and -200, in patients with recurrent PCa and other solid tumors, respectively. In 2010, Colby plans to launch a Phase I/IIa study of CPC-100 in men with PCa who fail Androgen Depletion Therapy, as evidenced by rising PSA levels. CPC-200 is being scheduled for a Phase I/IIa in men with high-risk tumors. Colby's two pipeline drugs, CPC-300 and CPC-410 for therapy-resistant metastatic and hypoxic tumors are in late pre-clinical development and are funded by federal grants, including an awarded Colby SBIR grant and by private investors. The Company has demonstrated safety of its lead drugs following efficacy studies in rodents and toxicology studies in mice, rats, and dogs. | Pharmaceuticals: Major | Corporate Officer/Principal | |
DERMIRA, INC. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
Kellogg School of Management | College/University | Masters Business Admin Graduate Degree | |
Northwestern University School of Law | College/University | Graduate Degree | |
CYTOMX THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
IO Biotech ApS
IO Biotech ApS BiotechnologyHealth Technology IO Biotech ApS operates as a clinical stage biotech company. It develops immunotherapy for cancer by targeting a mechanism used by tumour cells to evade immune responses. The company was founded by Mai-Britt Zocca, Mads Hald Andersen, Inge Marie Svane, Anders Ljungqvist and Per Thor Straten and is headquartered in Copenhagen, Denmark. | Biotechnology | Chairman | |
Allergy Amulet, Inc.
Allergy Amulet, Inc. Electronic Equipment/InstrumentsElectronic Technology Allergy Amulet, Inc. manufactures food allergen detection device. The firm enables mobile measurements to help individuals avoid ingesting target allergens The company was founded by Abigail Barnes and Joseph BelBruno and is headquartered in Madison, WI. | Electronic Equipment/Instruments | Director/Board Member | |
Escient Pharmaceuticals, Inc.
Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Escient Pharmaceuticals, Inc. operates as a bio-technology company. It develops in-class G Protein-Coupled Receptor targeted drugs to address serious, unserved medical needs. The company was founded by Alain D. Baron, Marcus F. Boehm and Xinzhong Dong and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member | |
ARCUTIS BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
TRex Bio Ltd.
TRex Bio Ltd. BiotechnologyHealth Technology TRex Bio Ltd. is a British company that provides biotechnology research and development services. The private company is based in London, UK. The company was founded in 2018 by Houman Ashrafian. | Biotechnology | Director/Board Member | |
CARGO THERAPEUTICS, INC. | Biotechnology | Director/Board Member General Counsel | |
INVIVYD, INC. | Biotechnology | Chief Operating Officer |
Statistieken
Internationaal
Verenigde Staten | 47 |
Spanje | 2 |
Denemarken | 2 |
Verenigd Koninkrijk | 2 |
Sectoraal
Health Technology | 29 |
Consumer Services | 11 |
Commercial Services | 7 |
Health Services | 3 |
Distribution Services | 2 |
Operationeel
Director/Board Member | 93 |
Corporate Officer/Principal | 87 |
Independent Dir/Board Member | 35 |
Undergraduate Degree | 21 |
Chief Executive Officer | 17 |
Sterkste connecties
Insiders | |
---|---|
Heath Lukatch | 43 |
Kurt von Emster | 34 |
Jonathon Mark Singer | 19 |
K. Hirth | 18 |
Anne Drapeau | 17 |
Halley Gilbert | 17 |
Mark Wiggins | 15 |
Michael Kamarck | 15 |
Carlos Paya | 14 |
Teri Loxam | 14 |
Andrew Guggenhime | 13 |
Jeff Fairman | 13 |
Elvia Cowan | 11 |
J. Frank Harmon | 9 |
James Wassil | 8 |
- Beurs
- Insiders
- Mikhail Eydelman
- Bedrijfsconnecties